Lumos Diagnostics Holdings Limited (ASX:LDX) Directors Insider Transactions
The Directors and Chief Executives of Lumos Diagnostics Holdings Limited (ASX:LDX) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Lumos Diagnostics Holdings Limited's shares in the stock market. Below table shows the list of insider transactions as reported by Lumos Diagnostics Holdings Limited to the ASX stock exchange.
An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.
Lumos Diagnostics Holdings Limited Directors/Insider Transactions Activity
List of Insider trades activity from Lumos Diagnostics Holdings Limited (LDX).
| Date | Director | Director's Title | Shares | Value | Note |
|---|---|---|---|---|---|
| 30 Jun 2025 | Lambert (Barrie) | Chief Financial Officer | 30,790 | - | - |
| 05 Dec 2024 | Ward (Doug) | Chief Executive Officer | 2,743,000 | 75,981 | Other at price 0.03 per share. |
| 09 Oct 2024 | Lanyon (Samuel) | Executive Chairman | 137,362 | 3,502 | Other at price 0.03 per share. |
| 09 Oct 2024 | Le Grice (Bronwyn) | Director (Non-Executive) | 60,970 | 1,554 | Other at price 0.03 per share. |
| 09 Oct 2024 | Robson (Catherine Anne) | Director (Non-Executive) | 734,940 | 18,740 | Other at price 0.03 per share. |
| 11 Jun 2024 | Robson (Catherine Anne) | Director (Non-Executive) | 312,500 | 7,000 | Purchase at price 0.02 per share. |
| 07 Jun 2024 | Lanyon (Samuel) | Executive Chairman | 250,000 | 4,925 | Purchase at price 0.02 per share. |